DHFR and cancer: An important target in cancer has been the folate pathway in which the enzyme dihydrofolate reductase (DHFR) enzyme catalyses the reduction of dihydrofolate to tetrahydrofolate using NADPH, which is an essential cofactor for the biosynthesis of purines, thymidylate, and several amino acids13–15.